Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Dual role of the colonization factor CD2831 in Clostridium difficile pathogenesis.

Arato V, Gasperini G, Giusti F, Ferlenghi I, Scarselli M, Leuzzi R.

Sci Rep. 2019 Apr 3;9(1):5554. doi: 10.1038/s41598-019-42000-8.

2.

Outer Membrane Vesicles (OMV)-based and Proteomics-driven Antigen Selection Identifies Novel Factors Contributing to Bordetella pertussis Adhesion to Epithelial Cells.

Gasperini G, Biagini M, Arato V, Gianfaldoni C, Vadi A, Norais N, Bensi G, Delany I, Pizza M, Aricò B, Leuzzi R.

Mol Cell Proteomics. 2018 Feb;17(2):205-215. doi: 10.1074/mcp.RA117.000045. Epub 2017 Dec 4.

3.

A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adults.

Leroux-Roels G, Lattanzi M, Solis CD, Contorni M, Costantini M, Moraschini L, Bardelli M, Bertholet S, Borgogni E, Buricchi F, Cantisani R, Faenzi E, Finco O, Leuzzi R, Pizza M, Rosa D, Schiavetti F, Seubert A, Spensieri F, Volpini G, Zedda L, Giudice GD, Galgani I.

Hum Vaccin Immunother. 2018 Jan 2;14(1):45-58. doi: 10.1080/21645515.2017.1385686. Epub 2017 Nov 27.

4.

Physiopathological roles of spontaneously released outer membrane vesicles of Bordetella pertussis.

Gasperini G, Arato V, Pizza M, Aricò B, Leuzzi R.

Future Microbiol. 2017 Nov;12:1247-1259. doi: 10.2217/fmb-2017-0064. Epub 2017 Oct 5.

PMID:
28980823
5.

Addition of a TLR7 agonist to an acellular pertussis vaccine enhances Th1 and Th17 responses and protective immunity in a mouse model.

Misiak A, Leuzzi R, Allen AC, Galletti B, Baudner BC, D'Oro U, O'Hagan DT, Pizza M, Seubert A, Mills KHG.

Vaccine. 2017 Sep 18;35(39):5256-5263. doi: 10.1016/j.vaccine.2017.08.009. Epub 2017 Aug 18.

6.

A novel high-throughput assay to quantify the vaccine-induced inhibition of Bordetella pertussis adhesion to airway epithelia.

Zanaboni E, Arato V, Pizza M, Seubert A, Leuzzi R.

BMC Microbiol. 2016 Sep 15;16:215. doi: 10.1186/s12866-016-0829-x.

7.

Structural characterization of zinc-bound Zmp1, a zinc-dependent metalloprotease secreted by Clostridium difficile.

Rubino JT, Martinelli M, Cantini F, Castagnetti A, Leuzzi R, Banci L, Scarselli M.

J Biol Inorg Chem. 2016 Apr;21(2):185-96. doi: 10.1007/s00775-015-1319-6. Epub 2015 Dec 28.

PMID:
26711661
8.

The potential of adjuvants to improve immune responses against TdaP vaccines: A preclinical evaluation of MF59 and monophosphoryl lipid A.

Agnolon V, Bruno C, Leuzzi R, Galletti B, D'Oro U, Pizza M, Seubert A, O'Hagan DT, Baudner BC.

Int J Pharm. 2015 Aug 15;492(1-2):169-76. doi: 10.1016/j.ijpharm.2015.06.030. Epub 2015 Jul 3.

PMID:
26149936
9.

Recombinant Clostridium difficile toxin fragments as carrier protein for PSII surface polysaccharide preserve their neutralizing activity.

Romano MR, Leuzzi R, Cappelletti E, Tontini M, Nilo A, Proietti D, Berti F, Costantino P, Adamo R, Scarselli M.

Toxins (Basel). 2014 Apr 22;6(4):1385-96. doi: 10.3390/toxins6041385.

10.

Vaccines against Clostridium difficile.

Leuzzi R, Adamo R, Scarselli M.

Hum Vaccin Immunother. 2014;10(6):1466-77. doi: 10.4161/hv.28428. Epub 2014 Mar 17. Review.

11.

Vaccination against Clostridium difficile using toxin fragments: Observations and analysis in animal models.

Spencer J, Leuzzi R, Buckley A, Irvine J, Candlish D, Scarselli M, Douce GR.

Gut Microbes. 2014 Mar-Apr;5(2):225-32. doi: 10.4161/gmic.27712. Epub 2014 Jan 22.

12.

Lipoprotein CD0873 is a novel adhesin of Clostridium difficile.

Kovacs-Simon A, Leuzzi R, Kasendra M, Minton N, Titball RW, Michell SL.

J Infect Dis. 2014 Jul 15;210(2):274-84. doi: 10.1093/infdis/jiu070. Epub 2014 Jan 29.

PMID:
24482399
13.

Identification of a novel zinc metalloprotease through a global analysis of Clostridium difficile extracellular proteins.

Cafardi V, Biagini M, Martinelli M, Leuzzi R, Rubino JT, Cantini F, Norais N, Scarselli M, Serruto D, Unnikrishnan M.

PLoS One. 2013 Nov 26;8(11):e81306. doi: 10.1371/journal.pone.0081306. eCollection 2013.

14.

Clostridium difficile toxins facilitate bacterial colonization by modulating the fence and gate function of colonic epithelium.

Kasendra M, Barrile R, Leuzzi R, Soriani M.

J Infect Dis. 2014 Apr 1;209(7):1095-104. doi: 10.1093/infdis/jit617. Epub 2013 Nov 22.

PMID:
24273043
15.

Neisseria gonorrhoeae PIII has a role on NG1873 outer membrane localization and is involved in bacterial adhesion to human cervical and urethral epithelial cells.

Leuzzi R, Nesta B, Monaci E, Cartocci E, Serino L, Soriani M, Rappuoli R, Pizza M.

BMC Microbiol. 2013 Nov 9;13:251. doi: 10.1186/1471-2180-13-251.

16.

Protective efficacy induced by recombinant Clostridium difficile toxin fragments.

Leuzzi R, Spencer J, Buckley A, Brettoni C, Martinelli M, Tulli L, Marchi S, Luzzi E, Irvine J, Candlish D, Veggi D, Pansegrau W, Fiaschi L, Savino S, Swennen E, Cakici O, Oviedo-Orta E, Giraldi M, Baudner B, D'Urzo N, Maione D, Soriani M, Rappuoli R, Pizza M, Douce GR, Scarselli M.

Infect Immun. 2013 Aug;81(8):2851-60. doi: 10.1128/IAI.01341-12. Epub 2013 May 28.

17.

CbpA: a novel surface exposed adhesin of Clostridium difficile targeting human collagen.

Tulli L, Marchi S, Petracca R, Shaw HA, Fairweather NF, Scarselli M, Soriani M, Leuzzi R.

Cell Microbiol. 2013 Oct;15(10):1674-87. doi: 10.1111/cmi.12139. Epub 2013 Apr 11.

PMID:
23517059
18.

Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile.

Ðapa T, Leuzzi R, Ng YK, Baban ST, Adamo R, Kuehne SA, Scarselli M, Minton NP, Serruto D, Unnikrishnan M.

J Bacteriol. 2013 Feb;195(3):545-55. doi: 10.1128/JB.01980-12. Epub 2012 Nov 21.

19.

Phosphorylation of the synthetic hexasaccharide repeating unit is essential for the induction of antibodies to Clostridium difficile PSII cell wall polysaccharide.

Adamo R, Romano MR, Berti F, Leuzzi R, Tontini M, Danieli E, Cappelletti E, Cakici OS, Swennen E, Pinto V, Brogioni B, Proietti D, Galeotti CL, Lay L, Monteiro MA, Scarselli M, Costantino P.

ACS Chem Biol. 2012 Aug 17;7(8):1420-8. doi: 10.1021/cb300221f. Epub 2012 Jun 7.

PMID:
22620974
20.

Molecular analysis of two novel Neisseria gonorrhoeae virulent components: the macrophage infectivity potentiator and the outer membrane protein A.

Starnino S, Leuzzi R, Ghisetti V, De Francesco MA, Cusini M, Impara G, Galluppi E, Pizza M, Stefanelli P.

New Microbiol. 2010 Apr;33(2):167-70.

21.

Identification of a new OmpA-like protein in Neisseria gonorrhoeae involved in the binding to human epithelial cells and in vivo colonization.

Serino L, Nesta B, Leuzzi R, Fontana MR, Monaci E, Mocca BT, Cartocci E, Masignani V, Jerse AE, Rappuoli R, Pizza M.

Mol Microbiol. 2007 Jun;64(5):1391-403.

22.

Ng-MIP, a surface-exposed lipoprotein of Neisseria gonorrhoeae, has a peptidyl-prolyl cis/trans isomerase (PPIase) activity and is involved in persistence in macrophages.

Leuzzi R, Serino L, Scarselli M, Savino S, Fontana MR, Monaci E, Taddei A, Fischer G, Rappuoli R, Pizza M.

Mol Microbiol. 2005 Nov;58(3):669-81.

23.

[Surgical treatment of breast cancer in the elderly].

Bacillari P, Leuzzi R, Meli L, Tomei B, Ruperto M, Zerilli M, Cicconetti F, Iascone C.

Minerva Chir. 2005 Jun;60(3):179-83. Italian.

PMID:
15985993
24.

Inhibition of microsomal glucose-6-phosphate transport in human neutrophils results in apoptosis: a potential explanation for neutrophil dysfunction in glycogen storage disease type 1b.

Leuzzi R, Bánhegyi G, Kardon T, Marcolongo P, Capecchi PL, Burger HJ, Benedetti A, Fulceri R.

Blood. 2003 Mar 15;101(6):2381-7. Epub 2002 Nov 7.

25.

Axillary lymphectomy in breast cancer.

Barillari P, Leuzzi R, D'Angelo F, Bassiri-Gharb A, Naticchioni E.

Minerva Chir. 2002 Apr;57(2):129-33.

PMID:
11941288
26.

Glucose 6-phosphate transport in fibroblast microsomes from glycogen storage disease type 1b patients: evidence for multiple glucose 6-phosphate transport systems.

Leuzzi R, Fulceri R, Marcolongo P, Bánhegyi G, Zammarchi E, Stafford K, Burchell A, Benedetti A.

Biochem J. 2001 Jul 15;357(Pt 2):557-62.

27.

[Ambulatory surgical treatment for breast carcinoma].

Barillari P, Leuzzi R, Bassiri-Gharb A, D'Angelo F, Aurello P, Naticchioni E.

Minerva Chir. 2001 Feb;56(1):55-9. Italian.

PMID:
11405187
28.

Bilateral vertebral artery dissection causing a cerebrovascular accident in pregnancy. A case report.

Mass SB, Cardonick E, Haas S, Gopalani S, Leuzzi RA.

J Reprod Med. 1999 Oct;44(10):887-90.

PMID:
10554752
29.

Rapamycin inhibits activation of ryanodine receptors from skeletal muscle by the fatty acyl CoA-acyl CoA binding protein complex.

Fulceri R, Giunti R, Knudsen J, Leuzzi R, Kardon T, Benedetti A.

Biochem Biophys Res Commun. 1999 Oct 22;264(2):409-12.

PMID:
10529377
30.
31.

Absence of mutations in the highest mutability region of the p53 gene in tumour-derived CHEF18 Chinese hamster cells.

Rainaldi G, Marchetti S, Capecchi B, Meneveri R, Piras A, Leuzzi R.

Mutagenesis. 1998 Mar;13(2):153-5.

PMID:
9568588
32.

Management of immune thrombocytopenic purpura associated with the antiphospholipid antibody syndrome.

Leuzzi RA, Davis GH, Cowchock FS, Murphy S, Vernick JJ.

Clin Exp Rheumatol. 1997 Mar-Apr;15(2):197-200.

PMID:
9196875
33.

Preconception counseling for the primary care physician.

Leuzzi RA, Scoles KS.

Med Clin North Am. 1996 Mar;80(2):337-74. Review.

PMID:
8614177
34.

[Results of conservative surgery in T1 breast carcinoma. Our experience in 66 treated cases].

Barillari P, Leuzzi R, Nardi M, Cerasi A, Calcaterra D, Cesareo S, Brandimarte A, Manetti G, Bovino A, Sammartino P.

Minerva Chir. 1994 Nov;49(11):1083-8. Italian.

PMID:
7708228
35.

Growth hormone release during insulin tolerance, clonidine, arginine and growth hormone releasing hormone tests in short normal children and adolescents.

Cavallo L, Acquafredda A, Liuzzi S, Russo R, Zecchino C, Leuzzi R, Giobbe T, Piacente L.

J Endocrinol Invest. 1992 Feb;15(2):131-5.

PMID:
1569289
36.

Wakefulness and sleep autonomic dysfunction in diabetics.

Silvestri R, Marabello L, Lasco A, Mento G, Raffaele M, Leuzzi R, Lombardo N, Di Perri R.

Funct Neurol. 1989 Apr-Jun;4(2):189-91.

PMID:
2737509
37.

[Minimal breast cancer. Analysis of 17 cases].

Leuzzi R, Barillari P, Bianco C, De Angelis R, Ramacciato G, Cerasi A.

Minerva Chir. 1988 Sep 30;43(18):1445-9. Italian. No abstract available.

PMID:
2852314
38.

[Prevalent and incident carcinomas diagnosed in a screening program for carcinoma of the breast].

Leuzzi R, Barillari P, Bianco C, Maccioni AF, Caruso L.

Minerva Chir. 1988 Sep 15;43(17):1355-8. Italian. No abstract available.

PMID:
3264890
39.

[Lobular neoplasm arising in a fibroadenoma. Clinical case report].

Leuzzi R, Barillari P, Bianco C, Caruso L, Ranieri E, Virno F.

Minerva Chir. 1988 Jun 30;43(12):1099-101. Italian. No abstract available.

PMID:
2845301
40.

Tissue CEA as prognostic indicator in a series of 44 cases of colorectal cancer.

Barillari P, Leuzzi R, Aurello P, Ramacciato G, Valabrega S, De Angelis R, Cecere A, Indinnimeo M, Gozzo P, Virno VA, et al.

Ital J Surg Sci. 1987;17(4):301-4.

PMID:
3329161

Supplemental Content

Loading ...
Support Center